P2.18-04 Real-world Study on Efficacy of First-Line Nivolumab + Ipilimumab in Unresectable Malignant Pleural Mesothelioma (ImmunoMeso).

Details

Language :

English

ISSN :

15560864

Volume :

18

Issue :

11

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

173323271

Full Text :

https://doi.org/10.1016/j.jtho.2023.09.677